# Nystatin

NDC: 0121-1045
Generic name: NYSTATIN
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20240621

FDA application: ANDA203621

## Active ingredients

- NYSTATIN: 100000 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-1045"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-1045
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05a8b8b6-3639-47b8-b7fc-47b105f5e6f9